DK0550031T3 - Medicinsk aerosolformulering - Google Patents
Medicinsk aerosolformuleringInfo
- Publication number
- DK0550031T3 DK0550031T3 DK92121985.3T DK92121985T DK0550031T3 DK 0550031 T3 DK0550031 T3 DK 0550031T3 DK 92121985 T DK92121985 T DK 92121985T DK 0550031 T3 DK0550031 T3 DK 0550031T3
- Authority
- DK
- Denmark
- Prior art keywords
- aerosol formulation
- medical aerosol
- active substance
- medical
- medicinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4143263 | 1991-12-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0550031T3 true DK0550031T3 (da) | 1996-08-26 |
Family
ID=6448287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92121985.3T DK0550031T3 (da) | 1991-12-31 | 1992-12-24 | Medicinsk aerosolformulering |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0550031B1 (da) |
JP (1) | JPH05279249A (da) |
AT (1) | ATE137666T1 (da) |
CA (1) | CA2086492A1 (da) |
DE (1) | DE59206234D1 (da) |
DK (1) | DK0550031T3 (da) |
ES (1) | ES2089357T3 (da) |
SG (1) | SG42375A1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4003270A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgase und ihre verwendung in arzneimittelzubereitungen |
ATE144151T1 (de) * | 1993-01-19 | 1996-11-15 | Hoechst Ag | Flüssiggasformulierung zur vitalitätsprüfung von zähnen |
US5679287A (en) | 1995-04-28 | 1997-10-21 | Great Lakes Chemical Corporation | Uses of heptafluoropropane |
US6039932A (en) * | 1996-09-27 | 2000-03-21 | 3M Innovative Properties Company | Medicinal inhalation aerosol formulations containing budesonide |
CA2280099C (en) | 1997-02-05 | 2005-12-27 | Jago Pharma Ag | Medical aerosol formulations |
US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
DE59911149D1 (de) | 1998-07-24 | 2004-12-30 | Jago Res Ag Muttenz | Medizinische aerosolformulierungen |
ATE234604T1 (de) | 1998-08-04 | 2003-04-15 | Jago Res Ag | Medizinische aerosolformulierungen |
US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
AU2862600A (en) * | 1999-01-29 | 2000-08-18 | Phylomed Corporation | Buccal delivery system |
DE60001492T2 (de) | 1999-04-14 | 2003-12-18 | Glaxo Group Ltd., Greenford | Pharmazeutische aerosolformulierung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
DE3905726A1 (de) * | 1989-02-24 | 1990-08-30 | Hoechst Ag | Druckgaspackung und treibmittel fuer aerosole |
EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
ES2200771T3 (es) * | 1991-06-10 | 2004-03-16 | Schering Corporation | Formulaciones en aerosol no clorofluorocarbonadas. |
-
1992
- 1992-12-24 EP EP92121985A patent/EP0550031B1/de not_active Revoked
- 1992-12-24 AT AT92121985T patent/ATE137666T1/de not_active IP Right Cessation
- 1992-12-24 DE DE59206234T patent/DE59206234D1/de not_active Revoked
- 1992-12-24 DK DK92121985.3T patent/DK0550031T3/da active
- 1992-12-24 SG SG9606946A patent/SG42375A1/en unknown
- 1992-12-24 ES ES92121985T patent/ES2089357T3/es not_active Expired - Lifetime
- 1992-12-28 JP JP4349041A patent/JPH05279249A/ja active Pending
- 1992-12-30 CA CA002086492A patent/CA2086492A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2086492A1 (en) | 1993-07-01 |
EP0550031A1 (de) | 1993-07-07 |
SG42375A1 (en) | 2001-04-17 |
EP0550031B1 (de) | 1996-05-08 |
DE59206234D1 (de) | 1996-06-13 |
ES2089357T3 (es) | 1996-10-01 |
ATE137666T1 (de) | 1996-05-15 |
JPH05279249A (ja) | 1993-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2111002A1 (en) | Non-Chlorofluorocarbon Aerosol Formulations | |
PT698393E (pt) | Agente de solubilizacao e preparacao para uso externo contendo o mesmo | |
CA2004598A1 (en) | Medicinal aerosol formulations | |
DK0553298T3 (da) | Aerosolformulering omfattende beclomethason-17,21-dipropionat | |
DE69132407D1 (de) | Aerosol arzneiformulierungen | |
ES2182357T3 (es) | Nueva utilizacion de budesonide y formoterol. | |
DK0550031T3 (da) | Medicinsk aerosolformulering | |
DE59400489D1 (de) | Fungizide Wirkstoffkombinationen | |
ATE215359T2 (de) | Aerosolformulierungen | |
ATE131730T1 (de) | Nukleosidanalogen enthaltende antiviren- zubereitungen | |
DE69021387D1 (de) | Medizinische aerosolformulierungen. | |
ES2093269T3 (es) | Microemulsiones del tipo agua en aceite. | |
MX9205384A (es) | Dispositivo de administracion transdermica de un agente activo para uso veterinario. | |
AU525695B2 (en) | Pharmaceutical formulations of prostacyclin | |
DK0626173T3 (da) | Aerosolpræparat indeholdende fusafungin | |
ES2131482A1 (es) | Formulacion acuosa de bambuterol. | |
GB2134783A (en) | Medical preparation having antitumoral effect | |
DE60017450D1 (de) | Pharmazeutische formulierungen enthaltend salmeterol | |
ITTO910597A1 (it) | Dospositivo di evaporazione sottovuoto di un agente di drogaggio, particolarmente berillio, e procedimento per effettuare tale drogaggio | |
GB2162746A (en) | Antiacidotic medicinal agent |